MedPath

Superficial Dry Needling for Cervicogenic Headache

Not Applicable
Conditions
Headache
Interventions
Other: Superficial Dry Needling
Other: Non-thrust Mobilizations only
Registration Number
NCT05444296
Lead Sponsor
Youngstown State University
Brief Summary

It is unknown if applying superficial dry needling to the trigeminal innervation field improves pain and disability for patients with cervicogenic headaches. The aim of this study is to determine if superficial dry needling of the trigeminal innervation field improves pain, neck mobility, and disability in patients with cervicogenic headaches. It will also be examined if psychosocial factors such as stress, anxiety, depression and self efficacy influence improvements in pain, range of motion and neck disability.

Detailed Description

Cervicogenic headache (CGH), is defined by the International Classification of Headache Disorders (ICHD) as a "headache caused by a disorder of the cervical spine and its component bony, disc, and/or soft tissue elements, usually but not invariably accompanied by neck pain. Prevalence of CGH in the general population is between .4-20%. Although the primary source of pain is generated from the upper cervical spinal levels, there is also neuro-anatomical basis of CGH involving the trigeminal nerve.

Dry needling (DN) is a widely used intervention performed by physical therapists for a wide range of musculoskeletal and neurological conditions. Dry needling has been shown to be beneficial for CGH but DN has only been investigated using trigger point DN to cervical musculature. Superficial DN also reduces pain associated to orthopedic spinal conditions and may be associated with a lower risk of post-treatment soreness.

Non-thrust mobilizations of the cervical spine are an accepted treatment known to reduce pain and disability associated with CGH. Their use has also been recommended in clinical practice guidelines.

This study aims to look investigate whether superficial dry needling targeting the trigeminal innervation sensory field will reduce pain and impairments known to exist in patients with CGH compared to mobilizations of the cervical spine. Mobilizations of the cervical spine are another common treatment that physical therapists employ to treat cervicogenic headaches.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
133
Inclusion Criteria
  • Aged 18 or older
  • Symptoms: (1)Unilateral pain starting in the neck and radiating to the frontotemporal region or posterior fossa, (2) pain aggravated by neck movement, (3) restricted cervical range of motion, (4) non-throbbing and non-lancinatingnpain, 5) dysfunction/headache pain in at least one of the joints of the upper cervical spine(C0-C4), and (6) headache frequency of at least 1 per week over a period greater than 3 months.
Exclusion Criteria
  • Headache or neck pain <2/10
  • Contraindications to the interventions
  • Whiplash associated disorder within 6 weeks
  • Pending litigation for neck pain and/or headache.
  • Unwilling to cease other care through duration of study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dry NeedlingSuperficial Dry NeedlingExperimental group
Upper Cervical MobilizationsNon-thrust Mobilizations onlyActive control
Dry NeedlingNon-thrust Mobilizations onlyExperimental group
Primary Outcome Measures
NameTimeMethod
Headache or neck pain intensity on a Numeric pain rating scale (0-10)<1 hour

0-10 scale pain intensity, 0 is no pain, 10 is severe pain, the lower the score the better

Secondary Outcome Measures
NameTimeMethod
Flexion Rotation Test in degrees of measurement<1 hour

Flexion-rotation test for CGH will be measured to determine any change in measure for c1-c2 mobility.

Short Form 36 (SF-36)<1 hour

Short Form-36 is used to assess quality of life. Each section of the Short Form 36 is scored with weight scores from 0-100. There is specific coding per section to assess different aspects of quality of life, for example physical functioning, emotional wellbeing. 100 in each section indicates a person is functioning at the highest level possible.

Severity Measure for Specific Phobia-Adult (SMSP-A)<1 hour

The Severity Measure for Specific Phobia-Adult assesses symptoms a person feels in response to injections and/or needles. It is scored 0-40 with higher scores indicating more severity of phobia of needles.

Active Range of Motion of the Cervical Spine in degrees of measurement<1 hour

Active range of motion will be measured in the most painful and or limited plane of movement.

Neck Disability Index (NDI)<1 hour

Neck Disability Index is used to assess how much an individual's neck pain affects daily life. The Neck Disability Index is scored from 0-50 and transformed into a percentage. This indicates the amount of disability someone has. The lower the score, the less disability is caused by neck pain.

Generalized Anxiety Disorder 7 (GAD-7)<1 hour

Generalized Anxiety Disorder-7 is used to assess the severity of anxiety an individual may have. The Generalized Anxiety Disorder 7 is scored from 0-21. A lower score indicates less severity of anxiety.

Patient Health Questionnaire - 9 (PHQ-9)<1 hour

Patient Health Questionnaire-9 is used to assess the severity of depression an individual may have. It is scored from 1-27. The lower the score, the lower the severity of depression an individual has.

Headache Self Efficacy Scale (HSES)<1 hour

Headache Self Efficacy Scale is used to assess an individual's belief they can do things to prevent headaches. Higher scores indicate higher self efficacy. The items have scoring from 1-7 with 1 being strongly disagree and 7 being strongly agree. Some items are reverse scored. The scores can range from 79-121.

Injection Phobia Scale (IPS)<1 hour

The Injection Phobia Scale assesses a person's fear or anxiety toward injections. It is scored 0-32 with the higher score indicating more severity of a phobia of injections.

Trial Locations

Locations (1)

Youngstown State University

🇺🇸

Youngstown, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath